NIH-funded research R01 grant

Targeting mitochondrial calcium uptake to treat ALS

Official title: Using Mitochondrial Ca2+ Uptake as a Therapeutic Target for ALS

Funded at University of Florida · NIH-11074123 · Data updated 2026-11-12

This study is looking at how calcium in tiny parts of cells called mitochondria affects the worsening of ALS, and it hopes to find out if changing calcium levels can help improve muscle and nerve function for people with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startMay 1, 2023
Project endApril 30, 2027
Funding year2025
Award (this year)$457,949
NIH project number5R01NS127858-03
Project IDNIH-11074123 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with amyotrophic lateral sclerosis.

Less likely to help

Patients with other neurodegenerative diseases or those under 21 years old may not benefit from this research.

What this research studies

This research investigates the role of mitochondrial calcium uptake in the progression of amyotrophic lateral sclerosis (ALS), a severe neurodegenerative disease. The study aims to understand how mitochondrial dysfunction in motor neurons and skeletal muscle contributes to ALS and whether reducing mitochondrial calcium uptake can improve muscle and nerve function. Using specialized mouse models, researchers will selectively manipulate mitochondrial calcium levels to assess their impact on disease progression and potential therapeutic outcomes. This approach could lead to new strategies for treating ALS by targeting the underlying cellular mechanisms involved in the disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic options that slow down or halt the progression of ALS.

How similar studies have gone: Previous research has shown promising results in targeting mitochondrial dysfunction in other neurodegenerative conditions, suggesting potential for success in this novel approach for ALS.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Wei-Lapierre, Lan — University of Florida
  • Study coordinator: Wei-Lapierre, Lan

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.